版本:
中国

BRIEF-Atossa Genetics receives approval from institutional review board for continuation of its fulvestrant microcatheter phase 2 study

May 9 Atossa Genetics Inc:

* Atossa Genetics receives approval from institutional review board for continuation of its fulvestrant microcatheter phase 2 study

* Atossa Genetics - institutional review board associated with montefiore medical center approved fulvestrant microcatheter phase 2 study Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐